Latest filing published 21 Jan 2026 for Acumen Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Amy Schacterle: trading record in brief
Amy Schacterle is a declared insider of Acumen Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 6 January 2025 to 16 January 2026.
Sales make up the whole of the open-market record (1 sale, €1,862). Other entries cover 2 share grants. So far in 2026, the count stands at no purchases and 1 sale.
Most recently, on 21 January 2026, the filings show a share grant in Acumen Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Amy Schacterle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 84,600 shares0Common StockSEC:0001628280-26-002957:0
- 1,097 shares@ US$1.9838100.0% of flowCommon StockSEC:0001628280-26-001633:0
- 8,800 shares0Common StockSEC:0001576885-25-000019:0
3 of 3 declarations
